Cryoneurolysis and Percutaneous Peripheral Nerve Stimulation to Treat Acute Pain.
Anesthesiology
; 133(5): 1127-1149, 2020 11 01.
Article
em En
| MEDLINE
| ID: mdl-32898231
ABSTRACT
Two regional analgesic modalities currently cleared by the U.S. Food and Drug Administration hold promise to provide postoperative analgesia free of many of the limitations of both opioids and local anesthetic-based techniques. Cryoneurolysis uses exceptionally low temperature to reversibly ablate a peripheral nerve, resulting in temporary analgesia. Where applicable, it offers a unique option given its extended duration of action measured in weeks to months after a single application. Percutaneous peripheral nerve stimulation involves inserting an insulated lead through a needle to lie adjacent to a peripheral nerve. Analgesia is produced by introducing electrical current with an external pulse generator. It is a unique regional analgesic in that it does not induce sensory, motor, or proprioception deficits and is cleared for up to 60 days of use. However, both modalities have limited validation when applied to acute pain, and randomized, controlled trials are required to define both benefits and risks.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Nervos Periféricos
/
Terapia por Estimulação Elétrica
/
Crioterapia
/
Dor Aguda
/
Manejo da Dor
/
Analgesia
Tipo de estudo:
Clinical_trials
Limite:
Humans
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article